Thu, 28 March 2024

News

Print

Back

News

Medical Cannabis for Fibromyalgia

a13.5.22.jpg
New research has been released for patients with Fibromyalgia which has assessed the effects seen in UK patients after being prescribed medical cannabis.

Symptoms commonly experienced in Fibromyalgia include anxiety, debilitating fatigue, chronic pain, sensitivity to light, sound, temperature and touch, as well as cognitive symptoms relating to short term memory or difficulty finding a word – often called ‘fibro fog’. Participants in the study – to be presented in full at the forthcoming International Cannabinoid Research Society (ICRS) Symposium June 25th – 30th – had an associated improvement in fibromyalgia symptoms and quality of life.

The study, a first in the UK, in addition to showing a reduction in fibromyalgia symptom severity found a 17% reduction in overall opiate use by patients.

Until now, there has been no recognised, formal diagnostic process for health care professionals. But fibromyalgia affects around 3 million people in the UK and is often a cause of ‘invisible’ disability. It affects women more often than men – with a typical onset between 35-50 years of age. This chronic condition causes pain in the muscles and tissues such as the tendons and ligaments. Sufferers experience tenderness in the upper chest and back, as well as neck, arms, and legs. Symptoms can be exacerbated by stress, cold weather and physical activity with patients reporting fatigue and extreme tiredness which is not relieved by rest.

Photo: SN

Details:

Date: 13 May 2022
Credits Publisher: Spiritual News

© 1998-2024 Spiritual® and Spiritual Search® are registered trademarks. The reproduction, even partial, of Spiritual contents is prohibited. Spiritual is not responsible in any way of the contents of the linked websites. Publishing House: Gruppo 4 s.r.l. VAT Registration number PD 02709800284 - IT E.U.
E-mail: staff@spiritual.eu

Engineered by Gruppo 4 s.r.l.